Company / Total Assets
Arcturus Therapeutics Holdings Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$271.1M
FY2025
5-year range
$271.1M / $450.4M
FY2021-FY2025
Trend
-21.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $450M in FY2022 to $271M in FY2025.
Based on SEC 10-K filings.
$271M in FY2025 with a 5-year CAGR of -10.7%.
Declined from $429M to $271M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -15.6%
- 5-Year CAGR
- -10.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcturus Therapeutics Holdings Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of -10.7%, indicating a declining trend.
- In FY2025, total assets decreased 21.2% year-over-year.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $271.1M | -21.2% |
| FY2024 | $344.1M | -19.9% |
| FY2023 | $429.4M | -4.7% |
| FY2022 | $450.4M | +14.7% |
| FY2021 | $392.8M | -17.6% |
| FY2020 | $476.5M | +480.0% |
| FY2019 | $82.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026